A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients - Trial NCT06377124
Access comprehensive clinical trial information for NCT06377124 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Not yet recruiting. The study focuses on Lung Cancer. Target enrollment is 320 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Hong Kong
Timeline & Enrollment
N/A
Apr 22, 2024
Jun 30, 2026
Primary Outcome
Change in health-related quality of life
Summary
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress,
 depression, sleep disturbance). The current study attempts to explore the efficacy of the
 Smart Self-Management Support Programme (3S) in improving quality of life of patients using
 self-management support programme with mobile devices.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06377124
Non-Device Trial